The 2019 ACR–SAA–SPARTAN treatment recommendations for axial spondyloarthritis incorporate useful advice on new therapies, treatment strategy and the use of imaging. But is it appropriate to still recommend different treatment strategies for non-radiographic and radiographic disease when available evidence suggests they are part of the same clinical spectrum?

中文翻译：

---

轴突性脊柱关节炎：停止分裂的时间为10年。

2019年ACR–SAA–SPARTAN的轴向性脊椎关节炎治疗建议结合了有关新疗法，治疗策略和影像学使用的有用建议。但是，在现有证据表明它们属于同一临床范围的情况下，仍然仍然建议对非放射线和放射线照相疾病采用不同的治疗策略是合适的吗？